Approximately 35 million individuals in the U.S. suffer from atopic dermatitis and psoriasis, highlighting a substantial market opportunity for ZORYVE products. Recognition of ZORYVE cream for ...

A new treatment could bring a smile to the faces of thousands who suffer from the skin disease psoriasis. Improved drugs are already bringing better control of the condition to many patients.

Arcutis is a rare topical dermatology player with accelerating launch metrics and continued growth. Read more about the ...

Tower 28 has earned the seal of approval to deal with rosacea, psoriasis and eczema from the three organizations that monitor skincare products for these conditions. The post Tower 28 earns three ...

Psoriasis is a tricky disease to manage ... the U.S. Food and Drug Administration approved Vtama (tapinarof) cream, an aryl hydrocarbon receptor agonist and the first FDA-approved steroid-free ...

Karishmma Chawla, a Functional Medicine & Lifestyle Educator, explains, “Food is the most intimate part of our body. It ...

Arcutis Biotherapeutics, Inc.’s ARQT share price has surged by 12.31%, which has investors questioning if this is right time ...

The uses of apple cider vinegar go way beyond the kitchen! That’s because the pantry staple is packed with nutrients that ...

CLEAN BEAUTY WITHOUT THE HYPE Clean beauty is not just a trend, it is the future of skincare. Alite stands for simple, ...

Gemma, 34, tried everything but creams from the doctor seemed to make the soreness, itching and bleeding worse ...

baths are a great way to ease the symptoms of psoriasis. Staying active, maintaining a balanced diet, and substituting your traditional hand soaps for the Epaderm Cream are various ways to support ...

Organon has shared positive results from a long-term extension (LTE) study of its Vtama (tapinarof) cream, 1% in atopic dermatitis (AD) patients aged as young as two years.